Riyadh, Saudi Arabia: PharmaResearch has officially launched its REJURAN skin booster in Saudi Arabia, marking another step in the companyโs expansion across the Middle Eastern medical aesthetics market. Launch symposiums held in Riyadh and Jeddah from September 11 to 12 brought together around 400 dermatologists, plastic surgeons and industry representatives.
The two-day events introduced REJURAN and PharmaResearchโs proprietary DOTโข PN technology, with discussions covering the productโs clinical applications and approaches to improving overall skin quality. Physicians showed particular interest in applications involving areas requiring precise treatment, including the eye area.
Click here to join our WhatsApp channel here
Korean medical experts also shared clinical techniques and treatment approaches, including combination procedures involving energy-based devices and methods designed to support patient convenience.
“This symposium was meaningful in that it enabled us to more actively communicate the clinical value of REJURAN in Saudi Arabia’s high-potential medical aesthetics market while expanding our engagement with local physicians,” a PharmaResearch representative said. “We will continue to strengthen the credibility and competitiveness of REJURAN across key Middle Eastern markets through educational and academic initiatives that enhance physicians’ understanding of the product and their experience using it.”
PharmaResearch entered the UAE market in 2024 and received medical device approval for REJURAN in Saudi Arabia in February 2026. Local distribution began in May through a regional partner, paving the way for the official launch.
Also read: UAE Expands Priority Groups for Seasonal Influenza Vaccination
The company plans to expand its network of local key opinion leaders and strengthen physician education and academic initiatives in Saudi Arabia. It also aims to establish the country as a key GCC growth market and use its regional presence to support wider expansion across the Middle East and North Africa.
The launch comes as demand for non-surgical aesthetic treatments continues to grow, alongside increasing interest in approaches focused on skin quality and regenerative aesthetics.









